-
EP4243789
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP4243789
| EP4243789 - COMPOSITIONS AND METHODS FOR STABILIZATION OF LIPID NANOPARTICLE MRNA VACCINES [Right-click to bookmark this link] | Status | Examination is in progress Status updated on 24.05.2024 Database last updated on 09.04.2026 | |
| Former | Request for examination was made Status updated on 18.08.2023 | ||
| Former | The international publication has been made Status updated on 21.05.2022 | ||
| Former | unknown Status updated on 07.12.2021 | Most recent event Tooltip | 24.02.2026 | New entry: Reply to examination report | Applicant(s) | For all designated states BioNTech SE An der Goldgrube 12 55131 Mainz / DE | [2023/38] | Inventor(s) | 01 /
PANZNER, Steffen 55131 Mainz / DE | 02 /
REINSCH, Christian 55131 Mainz / DE | 03 /
THANKI, Kaushik 55131 Mainz / DE | 04 /
SOMANI, Sukrut 55131 Mainz / DE | 05 /
TCHESSALOV, Serguei A. Andover, Massachusetts 01810 / US | 06 /
BHATNAGAR, Bakul Subodh Andover, Massachusetts 01810 / US | 07 /
DARVARI, Ramin Andover, Massachusetts 01810 / US | 08 /
LUTHRA, Sumit Andover, Massachusetts 01810 / US | [2023/38] | Representative(s) | Müller, Christian Stefan Gerd ZSP Patentanwälte PartG mbB Hansastraße 32 80686 München / DE | [2023/38] | Application number, filing date | 21814751.0 | 15.11.2021 | [2023/38] | WO2021EP81674 | Priority number, date | US202063114478P | 16.11.2020 Original published format: US 202063114478 P | US202063115588P | 18.11.2020 Original published format: US 202063115588 P | [2023/38] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2022101469 | Date: | 19.05.2022 | Language: | EN | [2022/20] | Type: | A1 Application with search report | No.: | EP4243789 | Date: | 20.09.2023 | Language: | EN | The application published by WIPO in one of the EPO official languages on 19.05.2022 takes the place of the publication of the European patent application. | [2023/38] | Search report(s) | International search report - published on: | EP | 19.05.2022 | Classification | IPC: | A61K9/51, A61K9/19, A61K39/00, A61P31/14 | [2023/38] | CPC: |
A61K9/19 (EP,IL,KR);
A61K9/5123 (EP,IL,KR,US);
A61K39/12 (EP,IL);
A61K39/215 (KR,US);
A61K47/18 (KR,US);
A61K47/24 (US);
A61K47/26 (KR,US);
A61K47/28 (US);
A61K9/5146 (US);
A61K9/5192 (US);
A61P31/14 (EP,IL,KR);
A61K2039/53 (EP,IL,KR);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2023/38] | Extension states | BA | 14.06.2023 | ME | 14.06.2023 | Title | German: | ZUSAMMENSETZUNGEN UND VERFAHREN ZUR STABILISIERUNG VON LIPIDNANOPARTIKEL-MRNA-IMPFSTOFFEN | [2023/38] | English: | COMPOSITIONS AND METHODS FOR STABILIZATION OF LIPID NANOPARTICLE MRNA VACCINES | [2023/38] | French: | COMPOSITIONS ET PROCÉDÉS DE STABILISATION DE VACCINS À ARNM À NANOPARTICULES LIPIDIQUES | [2023/38] | Entry into regional phase | 14.06.2023 | National basic fee paid | 14.06.2023 | Designation fee(s) paid | 14.06.2023 | Examination fee paid | Examination procedure | 16.05.2023 | Observations by third parties | 14.06.2023 | Examination requested [2023/38] | 14.06.2023 | Date on which the examining division has become responsible | 08.01.2024 | Amendment by applicant (claims and/or description) | 28.05.2024 | Despatch of a communication from the examining division (Time limit: M04) | 27.09.2024 | Reply to a communication from the examining division | 27.10.2025 | Despatch of a communication from the examining division (Time limit: M04) | 20.02.2026 | Reply to a communication from the examining division | Fees paid | Renewal fee | 22.11.2023 | Renewal fee patent year 03 | 20.11.2024 | Renewal fee patent year 04 | 19.11.2025 | Renewal fee patent year 05 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [A] WO2017218704 (MODERNATX INC et al.) | [A] WO2020072605 (INTELLIA THERAPEUTICS INC et al.) | [A] WO2017075531 (ACUITAS THERAPEUTICS INC et al.) | [A] WO2018078053 (CUREVAC AG et al.) | [A] "Advances in Genetics", vol. 88, 1 January 2014, ACADEMIC PRESS, US, ISSN: 0065-2660, article ALEX K.K. LEUNG ET AL: "Lipid Nanoparticles for Short Interfering RNA Delivery", pages: 71 - 110, XP055540398, DOI: 10.1016/B978-0-12-800148-6.00004-3 DOI: http://dx.doi.org/10.1016/B978-0-12-800148-6.00004-3 | by applicant | EP2020081981 | WO2016005324 | WO2017075531 | MEYERSMILLER, CABIOS, vol. 4, 1989, pages 11 - 17 | JOSE ET AL., FUTURE MICROBIOL., vol. 4, 2009, pages 837 - 856 | GOULD, ANTIVIRAL RES., vol. 87, 2010, pages 111 - 124 | HOLTKAMP ET AL., BLOOD, vol. 108, 2006, pages 4009 - 4017 |